ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BLCO Bausch plus Lomb Corporation

14.94
0.00 (0.00%)
18 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bausch plus Lomb Corporation NYSE:BLCO NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.94 0 01:00:00

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 Financial Results on February 21

05/02/2024 5:00pm

Business Wire


Bausch plus Lomb (NYSE:BLCO)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Bausch plus Lomb Charts.

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2023 financial results on Wednesday, Feb. 21, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:

 

Wednesday, Feb. 21, 2024

 

Time:

 

8 a.m. ET

 

Webcast:

 

https://www.webcaster4.com/Webcast/Page/2883/49630

 

Participant Event Dial-in:

 

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

 

Participant Access Code:

 

181271

 

Replay Dial-in:

 

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

 

Replay Passcode:

 

49630 (replay available until March 6, 2024)

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

© 2024 Bausch + Lomb.

Media Contact: T.J. Crawford tj.crawford@bausch.com (908) 705-2851

Investor Contact: George Gadkowski george.gadkowski@bausch.com (877) 354-3705 (toll free) (908) 927-0735

1 Year Bausch plus Lomb Chart

1 Year Bausch plus Lomb Chart

1 Month Bausch plus Lomb Chart

1 Month Bausch plus Lomb Chart

Your Recent History

Delayed Upgrade Clock